Hologic, Inc. $HOLX Shares Purchased by Gotham Asset Management LLC

Gotham Asset Management LLC grew its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 74.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 639,921 shares of the medical equipment provider’s stock after buying an additional 272,477 shares during the period. Gotham Asset Management LLC owned 0.29% of Hologic worth $43,188,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Hologic by 10.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,776 shares of the medical equipment provider’s stock valued at $2,395,000 after purchasing an additional 3,520 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of Hologic by 27.7% during the 1st quarter. Empowered Funds LLC now owns 17,494 shares of the medical equipment provider’s stock worth $1,081,000 after purchasing an additional 3,790 shares during the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of Hologic during the 2nd quarter worth about $454,000. Allworth Financial LP grew its holdings in shares of Hologic by 120.3% during the second quarter. Allworth Financial LP now owns 1,511 shares of the medical equipment provider’s stock worth $98,000 after buying an additional 825 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Hologic by 1.7% in the second quarter. Geode Capital Management LLC now owns 5,828,325 shares of the medical equipment provider’s stock valued at $378,209,000 after buying an additional 97,142 shares during the last quarter. 94.73% of the stock is currently owned by hedge funds and other institutional investors.

Hologic Price Performance

HOLX opened at $75.12 on Monday. The company’s 50 day simple moving average is $75.13 and its 200 day simple moving average is $72.72. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.32 and a current ratio of 4.04. Hologic, Inc. has a 1 year low of $51.90 and a 1 year high of $75.75. The stock has a market capitalization of $16.77 billion, a PE ratio of 31.30, a P/E/G ratio of 2.24 and a beta of 0.73.

Hologic (NASDAQ:HOLX) last issued its quarterly earnings results on Thursday, January 29th. The medical equipment provider reported $1.04 EPS for the quarter, missing the consensus estimate of $1.09 by ($0.05). The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.07 billion. Hologic had a return on equity of 19.58% and a net margin of 13.18%.The business’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same period last year, the company posted $0.87 EPS. As a group, sell-side analysts expect that Hologic, Inc. will post 4.28 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HOLX. BNP Paribas Exane downgraded shares of Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 price objective on the stock. in a research note on Friday, November 21st. Evercore cut shares of Hologic from an “outperform” rating to an “in-line” rating and lowered their target price for the stock from $79.00 to $78.00 in a research note on Monday, January 5th. Argus downgraded Hologic from a “buy” rating to a “hold” rating in a report on Monday, January 12th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Hologic in a research note on Wednesday, January 28th. Two analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to MarketBeat.com, Hologic currently has a consensus rating of “Hold” and an average price target of $78.42.

Hologic Profile

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.